MORGAN VENTURES LTD.

Morgan Ventures Ltd has announced its 39th Annual General Meeting (AGM) scheduled for September 02, 2026, to be conducted via Video Conferencing. The company has submitted its Annual Report for the Financial Year 2025-26, along with the Notice of the 39th AGM, in compliance with SEBI regulations. The Annual Report and AGM Notice are accessible on the company's website, www.morganventures.in. The report details company information, directors' reports, financial statements, and various annexures including CSR activities, management discussion, and corporate governance.

Morgan Ventures Ltd announced that its Board of Directors, in a meeting held on August 7, 2026, approved the unaudited standalone financial results for the first quarter ended June 30, 2026. The Board also approved the reappointment of Mr. Kuldeep Kumar Dhar as Managing Director for a period of five years, effective August 14, 2026, subject to shareholder approval at the upcoming 39th Annual General Meeting. The AGM is scheduled for September 2, 2026.

Morgan Ventures Ltd announced its unaudited standalone financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results, which were subject to a limited review by statutory auditors. Additionally, the Board reappointed Mr. Kuldeep Kumar Dhar as Managing Director for a term of five years, effective August 14, 2026, subject to shareholder approval at the upcoming 39th Annual General Meeting. The AGM is scheduled for September 02, 2026.

Morgan Ventures Ltd announced the reappointment of Mr. Kuldeep Kumar Dhar as Managing Director for a term of five years, effective from August 14, 2026, to August 13, 2031. This decision was made by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. The reappointment is subject to shareholder approval at the upcoming 39th Annual General Meeting. Mr. Dhar, who is not liable to retire by rotation, has five decades of experience in business development, arbitration, accounts, legal, and management. He is not related to any other director and is not debarred from holding a directorial office.

Morgan Ventures Ltd has announced that its Board of Directors will convene on August 7, 2026, to consider and approve the Un-Audited Financial Results for the quarter ending June 30, 2026. The meeting is scheduled to take place at 3:30 PM at their New Delhi office. Additionally, the company confirmed that the trading window for its designated persons will remain closed from July 1, 2026, and will reopen 48 hours after the financial results are declared.

Morgan Ventures Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Un-audited Financial Results for the quarter ended June 30, 2026. All promoters, directors, designated persons, connected persons, and their immediate relatives are prohibited from trading during this period. The date for the board meeting to approve these financial results will be communicated separately.

Morgan Ventures Ltd has reappointed Mr. Sanjiv Bansal as an Independent Director for a second term of 5 years, effective from June 17, 2026. The reappointment, based on the recommendation of the Nomination and Remuneration Committee and approved by the Board of Directors on May 29, 2026, is subject to the approval of the company's members. Mr. Bansal's new term will last until June 17, 2031.

Morgan Ventures Ltd has reappointed Mr. Sanjiv Bansal as an Independent Director for a second term of 5 years, effective from June 17, 2026, until June 17, 2031. This reappointment is based on the recommendation of the Nomination and Remuneration Committee and the approval of the Board of Directors at their meeting held on May 29, 2026, and is subject to the approval of the company's members. Dr. Bansal is a physician with experience in diagnosing and managing medical conditions and owns Bansal Hospitals in Delhi.

Morgan Ventures Ltd has appointed H. Tara & Co., Practicing Cost Accountants, as the Internal Auditor for the financial year 2026-2027. The appointment was made during the Board of Directors meeting held on May 29, 2026. H. Tara & Co. confirmed they do not suffer from any disqualifications under the Companies Act, 2013 and are an independent firm at arm’s length with the company.

Morgan Ventures Ltd's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026, in a meeting held on May 29, 2026. The board also reviewed the auditor's report with an unmodified opinion. A legal matter concerning land valued at ₹320.02 crore is ongoing, with the company contesting the revocation of lease rights by MIDC in the Bombay High Court. The court has allowed MIDC symbolic possession only, pending the final order.